{"transactions":[{"id":858210,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-05T21:08:15.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":5272,"price":28.88,"value":152255.36,"ownership":{"direct":true},"balance_after":868,"source":{"system":"sec-edgar","filing":"0001439222-26-000046","document":"wk-form4_1772744891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000046/wk-form4_1772744891.xml","form_type":"4"}},{"id":866549,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":2695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":5390,"derivative":{"underlying":"Common stock","underlying_shares":2695},"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866548,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":2450,"derivative":{"underlying":"Common stock","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866547,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2350},"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866546,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-01","kind":"grant","planned":true,"acquired":true,"shares":8452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":8452,"derivative":{"underlying":"Common stock","underlying_shares":8452},"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866545,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":798,"price":28.96,"value":23110.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025."}],"balance_after":6140,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866544,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":2695,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6938,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866543,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":727,"price":28.96,"value":21053.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024."}],"balance_after":4243,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866542,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4970,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866541,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":698,"price":28.96,"value":20214.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023."}],"balance_after":2595,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":866540,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2026-03-03T21:12:38.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 75 shares purchased through the Company's employee stock purchase plan."}],"balance_after":3293,"source":{"system":"sec-edgar","filing":"0001439222-26-000034","document":"wk-form4_1772572356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000034/wk-form4_1772572356.xml","form_type":"4"}},{"id":1044734,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-09-09T20:26:17.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":8546,"price":36.87,"value":315091.02,"ownership":{"direct":true},"balance_after":868,"source":{"system":"sec-edgar","filing":"0001439222-25-000102","document":"wk-form4_1757449574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000102/wk-form4_1757449574.xml","form_type":"4"}},{"id":1227864,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":4900,"derivative":{"underlying":"Common stock","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227863,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"exercise","planned":true,"acquired":false,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":2350,"derivative":{"underlying":"Common stock","underlying_shares":2350},"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227862,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"exercise","planned":true,"acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227861,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"grant","planned":true,"acquired":true,"shares":6142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units were granted on March 1, 2025. On February 1, 2027, the shares underlying the restricted stock units will vest in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units were granted on March 1, 2025. On February 1, 2027, the shares underlying the restricted stock units will vest in full."}],"balance_after":6142,"derivative":{"underlying":"Common stock","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227860,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"grant","planned":true,"acquired":true,"shares":8085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":8085,"derivative":{"underlying":"Common stock","underlying_shares":8085},"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227859,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":727,"price":35.54,"value":25837.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024."}],"balance_after":9414,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227858,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"exercise","planned":true,"acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10141,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227857,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":697,"price":35.54,"value":24771.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023."}],"balance_after":7691,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227856,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"exercise","planned":true,"acquired":true,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8388,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227855,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":231,"price":35.54,"value":8209.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022."}],"balance_after":6038,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1227854,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-03-04T21:06:56.000Z","date":"2025-03-01","kind":"exercise","planned":true,"acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55 shares purchased through the Company's employee stock purchase plan."}],"balance_after":6269,"source":{"system":"sec-edgar","filing":"0001439222-25-000011","document":"wk-form4_1741122407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000011/wk-form4_1741122407.xml","form_type":"4"}},{"id":1281709,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2025-02-05T21:02:49.000Z","date":"2025-02-01","kind":"exercise","planned":true,"acquired":false,"shares":6896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025"}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":6896},"source":{"system":"sec-edgar","filing":"0001439222-25-000004","document":"wk-form4_1738789362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000004/wk-form4_1738789362.xml","form_type":"4"}},{"id":1281708,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-02-05T21:02:49.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":2272,"price":34.39,"value":78134.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated February 1, 2023."}],"balance_after":5437,"source":{"system":"sec-edgar","filing":"0001439222-25-000004","document":"wk-form4_1738789362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000004/wk-form4_1738789362.xml","form_type":"4"}},{"id":1281707,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2025-02-05T21:02:49.000Z","date":"2025-02-01","kind":"exercise","planned":true,"acquired":true,"shares":6896,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7709,"source":{"system":"sec-edgar","filing":"0001439222-25-000004","document":"wk-form4_1738789362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000004/wk-form4_1738789362.xml","form_type":"4"}},{"id":1366464,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-11-13T21:14:37.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":772,"price":56.09,"value":43301.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of 813 shares purchased through the Company's employee stock purchase plan."}],"balance_after":813,"source":{"system":"sec-edgar","filing":"0001439222-24-000144","document":"wk-form4_1731532469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000144/wk-form4_1731532469.xml","form_type":"4"}},{"id":1489900,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-06-05T20:14:51.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":1362,"price":44.39,"value":60459.18,"ownership":{"direct":true},"balance_after":1524,"source":{"system":"sec-edgar","filing":"0001439222-24-000071","document":"wk-form4_1717618483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000071/wk-form4_1717618483.xml","form_type":"4"}},{"id":1588997,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-03-07T23:47:57.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":1913,"price":31.75,"value":60737.75,"ownership":{"direct":true},"balance_after":2886,"source":{"system":"sec-edgar","filing":"0001439222-24-000056","document":"wk-form4_1709855269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000056/wk-form4_1709855269.xml","form_type":"4"}},{"id":1595541,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":false,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":4700,"derivative":{"underlying":"Common stock","underlying_shares":2350},"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595540,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":777,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595539,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-01","kind":"grant","planned":true,"acquired":true,"shares":7350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":7350,"derivative":{"underlying":"Common stock","underlying_shares":7350},"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595538,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":919,"price":32.57,"value":29931.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023."}],"balance_after":4799,"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595537,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":true,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5718,"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595536,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":295,"price":32.57,"value":9608.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022."}],"balance_after":3368,"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1595535,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-03-05T21:15:23.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 752 shares purchased through the Company's employee stock purchase plan."}],"balance_after":3663,"source":{"system":"sec-edgar","filing":"0001439222-24-000050","document":"wk-form4_1709673296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000050/wk-form4_1709673296.xml","form_type":"4"}},{"id":1625221,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-02-22T22:43:34.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":504,"price":26.63,"value":13421.52,"ownership":{"direct":true},"balance_after":2741,"source":{"system":"sec-edgar","filing":"0001439222-24-000037","document":"wk-form4_1708641780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000037/wk-form4_1708641780.xml","form_type":"4"}},{"id":1643028,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2024-02-14T22:50:21.000Z","date":"2024-02-12","kind":"exercise","planned":true,"acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-24-000026","document":"wk-form4_1707951005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000026/wk-form4_1707951005.xml","form_type":"4"}},{"id":1643027,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-02-14T22:50:21.000Z","date":"2024-02-14","kind":"sale","planned":true,"acquired":false,"shares":273,"price":25.14,"value":6863.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated February 10, 2021."}],"balance_after":3245,"source":{"system":"sec-edgar","filing":"0001439222-24-000026","document":"wk-form4_1707951005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000026/wk-form4_1707951005.xml","form_type":"4"}},{"id":1643026,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2024-02-14T22:50:21.000Z","date":"2024-02-12","kind":"exercise","planned":true,"acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3518,"source":{"system":"sec-edgar","filing":"0001439222-24-000026","document":"wk-form4_1707951005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000026/wk-form4_1707951005.xml","form_type":"4"}},{"id":1811905,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-08-09T20:04:53.000Z","date":"2023-08-07","kind":"sale","planned":false,"acquired":false,"shares":2918,"price":25.3927,"value":74095.8986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.22 to $25.40. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2741,"source":{"system":"sec-edgar","filing":"0001439222-23-000121","document":"wk-form4_1691611481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000121/wk-form4_1691611481.xml","form_type":"4"}},{"id":1817860,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-08-02T20:02:49.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":false,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on August 1, 2021. The shares underlying the stock units will vest in full on August 1, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on August 1, 2021. The shares underlying the stock units will vest in full on August 1, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested"}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001439222-23-000113","document":"wk-form4_1691006558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000113/wk-form4_1691006558.xml","form_type":"4"}},{"id":1817859,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-08-02T20:02:49.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":1232,"price":26.26,"value":32352.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units."}],"balance_after":5659,"source":{"system":"sec-edgar","filing":"0001439222-23-000113","document":"wk-form4_1691006558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000113/wk-form4_1691006558.xml","form_type":"4"}},{"id":1817858,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-08-02T20:02:49.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":true,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6891,"source":{"system":"sec-edgar","filing":"0001439222-23-000113","document":"wk-form4_1691006558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000113/wk-form4_1691006558.xml","form_type":"4"}},{"id":1965631,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-03-07T21:02:47.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":504,"price":24.29,"value":12242.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2741,"source":{"system":"sec-edgar","filing":"0001439222-23-000053","document":"wf-form4_167822295304274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000053/wf-form4_167822295304274.xml","form_type":"4"}},{"id":1972885,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-03-03T21:08:30.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":1554,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-23-000051","document":"wf-form4_167787764712794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000051/wf-form4_167787764712794.xml","form_type":"4"}},{"id":1972884,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-03-03T21:08:30.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":7050,"derivative":{"underlying":"Common stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001439222-23-000051","document":"wf-form4_167787764712794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000051/wf-form4_167787764712794.xml","form_type":"4"}},{"id":1972883,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-03-03T21:08:30.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":273,"price":25.31,"value":6909.63,"ownership":{"direct":true},"balance_after":3245,"source":{"system":"sec-edgar","filing":"0001439222-23-000051","document":"wf-form4_167787764712794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000051/wf-form4_167787764712794.xml","form_type":"4"}},{"id":1972882,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-03-03T21:08:30.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 73 shares purchased through the Company's employee stock purchase plan."}],"balance_after":3518,"source":{"system":"sec-edgar","filing":"0001439222-23-000051","document":"wf-form4_167787764712794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000051/wf-form4_167787764712794.xml","form_type":"4"}},{"id":2003318,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-21T21:05:24.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":233,"price":27.21,"value":6339.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2668,"source":{"system":"sec-edgar","filing":"0001439222-23-000028","document":"wf-form4_167701349283143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000028/wf-form4_167701349283143.xml","form_type":"4"}},{"id":2010878,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-02-16T21:04:58.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001439222-23-000026","document":"wf-form4_167658147701426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000026/wf-form4_167658147701426.xml","form_type":"4"}},{"id":2010877,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-16T21:04:58.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":504,"price":28.59,"value":14409.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2901,"source":{"system":"sec-edgar","filing":"0001439222-23-000026","document":"wf-form4_167658147701426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000026/wf-form4_167658147701426.xml","form_type":"4"}},{"id":2010876,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-16T21:04:58.000Z","date":"2023-02-14","kind":"tax_withholding","acquired":false,"shares":127,"price":28.91,"value":3671.57,"ownership":{"direct":true},"balance_after":3405,"source":{"system":"sec-edgar","filing":"0001439222-23-000026","document":"wf-form4_167658147701426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000026/wf-form4_167658147701426.xml","form_type":"4"}},{"id":2010875,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-16T21:04:58.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3532,"source":{"system":"sec-edgar","filing":"0001439222-23-000026","document":"wf-form4_167658147701426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000026/wf-form4_167658147701426.xml","form_type":"4"}},{"id":2016145,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-02-14T21:06:35.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":777,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-23-000016","document":"wf-form4_167640875313872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000016/wf-form4_167640875313872.xml","form_type":"4"}},{"id":2016144,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2023-02-14T21:06:35.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":6896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025."}],"balance_after":6896,"derivative":{"underlying":"Common stock","underlying_shares":6896},"source":{"system":"sec-edgar","filing":"0001439222-23-000016","document":"wf-form4_167640875313872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000016/wf-form4_167640875313872.xml","form_type":"4"}},{"id":2016143,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-14T21:06:35.000Z","date":"2023-02-14","kind":"tax_withholding","acquired":false,"shares":273,"price":28.44,"value":7764.12,"ownership":{"direct":true},"balance_after":3172,"source":{"system":"sec-edgar","filing":"0001439222-23-000016","document":"wf-form4_167640875313872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000016/wf-form4_167640875313872.xml","form_type":"4"}},{"id":2016142,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2023-02-14T21:06:35.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 119 shares purchased through the Company's employee stock purchase plan."}],"balance_after":3445,"source":{"system":"sec-edgar","filing":"0001439222-23-000016","document":"wf-form4_167640875313872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000016/wf-form4_167640875313872.xml","form_type":"4"}},{"id":2353909,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock options (right to buy)","published_at":"2022-03-03T21:10:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":1165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":1165,"derivative":{"exercise_price":32.2,"expiration_date":"2032-03-01","underlying":"Common stock","underlying_shares":1165},"source":{"system":"sec-edgar","filing":"0001439222-22-000028","document":"wf-form4_164634178943965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000028/wf-form4_164634178943965.xml","form_type":"4"}},{"id":2353908,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2022-03-03T21:10:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":2331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":2331,"derivative":{"underlying":"Common stock","underlying_shares":2331},"source":{"system":"sec-edgar","filing":"0001439222-22-000028","document":"wf-form4_164634178943965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000028/wf-form4_164634178943965.xml","form_type":"4"}},{"id":2365091,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-03-01T21:54:37.000Z","date":"2022-02-25","kind":"sale","acquired":false,"shares":108,"price":30,"value":3240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2549,"source":{"system":"sec-edgar","filing":"0001439222-22-000025","document":"wf-form4_164617164759062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000025/wf-form4_164617164759062.xml","form_type":"4"}},{"id":2378309,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2022-02-23T21:09:03.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on  February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on  February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":167},"source":{"system":"sec-edgar","filing":"0001439222-22-000014","document":"wf-form4_164565050562951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000014/wf-form4_164565050562951.xml","form_type":"4"}},{"id":2378308,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:09:03.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":59,"price":29.08,"value":1715.72,"ownership":{"direct":true},"balance_after":2657,"source":{"system":"sec-edgar","filing":"0001439222-22-000014","document":"wf-form4_164565050562951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000014/wf-form4_164565050562951.xml","form_type":"4"}},{"id":2378307,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:09:03.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2716,"source":{"system":"sec-edgar","filing":"0001439222-22-000014","document":"wf-form4_164565050562951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000014/wf-form4_164565050562951.xml","form_type":"4"}},{"id":2385195,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-18T21:56:05.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":233,"price":30.81,"value":7178.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2549,"source":{"system":"sec-edgar","filing":"0001439222-22-000013","document":"wf-form4_164522134427957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000013/wf-form4_164522134427957.xml","form_type":"4"}},{"id":2391695,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2022-02-16T22:00:33.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":360,"derivative":{"underlying":"Common stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001439222-22-000009","document":"wf-form4_164504880629063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000009/wf-form4_164504880629063.xml","form_type":"4"}},{"id":2391694,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:00:33.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":504,"price":31.25,"value":15750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2782,"source":{"system":"sec-edgar","filing":"0001439222-22-000009","document":"wf-form4_164504880629063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000009/wf-form4_164504880629063.xml","form_type":"4"}},{"id":2391693,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:00:33.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":127,"price":30.5,"value":3873.5,"ownership":{"direct":true},"balance_after":3286,"source":{"system":"sec-edgar","filing":"0001439222-22-000009","document":"wf-form4_164504880629063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000009/wf-form4_164504880629063.xml","form_type":"4"}},{"id":2391692,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:00:33.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34 shares purchased through the Company's employee stock purchase plan."}],"balance_after":3413,"source":{"system":"sec-edgar","filing":"0001439222-22-000009","document":"wf-form4_164504880629063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000009/wf-form4_164504880629063.xml","form_type":"4"}},{"id":2397750,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted stock units","published_at":"2022-02-14T21:08:46.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":1554,"derivative":{"underlying":"Common stock","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001439222-22-000007","document":"wf-form4_164487289859926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000007/wf-form4_164487289859926.xml","form_type":"4"}},{"id":2397749,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:08:46.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":273,"price":31.425,"value":8579.025,"ownership":{"direct":true},"balance_after":3019,"source":{"system":"sec-edgar","filing":"0001439222-22-000007","document":"wf-form4_164487289859926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000007/wf-form4_164487289859926.xml","form_type":"4"}},{"id":2397748,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":62539,"kind":"person","name":"Washburn Theodore James Jr.","position":1,"cik":"0001874199","reported_name":"Washburn Theodore James Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:08:46.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":3292,"source":{"system":"sec-edgar","filing":"0001439222-22-000007","document":"wf-form4_164487289859926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000007/wf-form4_164487289859926.xml","form_type":"4"}}]}